Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56.
JAMA. 2006.
PMID: 16820547
Clinical Trial.
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.
Gonzales D, et al.
JAMA. 2006 Jul 5;296(1):47-55. doi: 10.1001/jama.296.1.47.
JAMA. 2006.
PMID: 16820546
Clinical Trial.
Item in Clipboard
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group.
Tonstad S, et al.
JAMA. 2006 Jul 5;296(1):64-71. doi: 10.1001/jama.296.1.64.
JAMA. 2006.
PMID: 16820548
Clinical Trial.
Item in Clipboard
Cite
Cite